世界の内在性カンナビノイドシステム標的治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Endocannabinoid System Targeted Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4185 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、内在性カンナビノイドシステム標的治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、吸入、その他）、用途別市場規模（自己免疫疾患、遺伝性疾患、神経疾患、疼痛性疾患）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・内在性カンナビノイドシステム標的治療の市場動向 ・企業の競争状況、市場シェア ・内在性カンナビノイドシステム標的治療の種類別市場規模と予測2016-2027（経口、吸入、その他） ・内在性カンナビノイドシステム標的治療の用途別市場規模と予測2016-2027（自己免疫疾患、遺伝性疾患、神経疾患、疼痛性疾患） ・内在性カンナビノイドシステム標的治療の北米市場規模2016-2027（アメリカ、カナダ） ・内在性カンナビノイドシステム標的治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・内在性カンナビノイドシステム標的治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・内在性カンナビノイドシステム標的治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・内在性カンナビノイドシステム標的治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GW Pharmaceuticals、MAKScientific、Corbus Pharmaceuticals、Tilray、Pure Green、Avicanna、GB Sciences、Botanix Pharmaceuticals、Therapix Biosciences、Zelira Therapeutics） ・結論

Endocannabinoid System Targeted Therapeutics refers to the use of the endocannabinoid system as a therapeutic target to treat some diseases

Market Analysis and Insights: Global Endocannabinoid System Targeted Therapeutics Market
The global Endocannabinoid System Targeted Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endocannabinoid System Targeted Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endocannabinoid System Targeted Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endocannabinoid System Targeted Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endocannabinoid System Targeted Therapeutics market.

Global Endocannabinoid System Targeted Therapeutics Scope and Market Size
Endocannabinoid System Targeted Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Endocannabinoid System Targeted Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Inhalation
Others

Segment by Application
Autoimmune Disorders
Genetic Disorders
Neurological Disorders
Pain Disorders

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GW Pharmaceuticals
MAKScientific
Corbus Pharmaceuticals
Tilray
Pure Green
Avicanna
GB Sciences
Botanix Pharmaceuticals
Therapix Biosciences
Zelira Therapeutics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Inhalation
1.2.4 Others
1.3 Market by Application
1.3.1 Global Endocannabinoid System Targeted Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Autoimmune Disorders
1.3.3 Genetic Disorders
1.3.4 Neurological Disorders
1.3.5 Pain Disorders
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Endocannabinoid System Targeted Therapeutics Market Perspective (2016-2027)
2.2 Endocannabinoid System Targeted Therapeutics Growth Trends by Regions
2.2.1 Endocannabinoid System Targeted Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Endocannabinoid System Targeted Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Endocannabinoid System Targeted Therapeutics Industry Dynamic
2.3.1 Endocannabinoid System Targeted Therapeutics Market Trends
2.3.2 Endocannabinoid System Targeted Therapeutics Market Drivers
2.3.3 Endocannabinoid System Targeted Therapeutics Market Challenges
2.3.4 Endocannabinoid System Targeted Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Endocannabinoid System Targeted Therapeutics Players by Revenue
3.1.1 Global Top Endocannabinoid System Targeted Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Endocannabinoid System Targeted Therapeutics Revenue
3.4 Global Endocannabinoid System Targeted Therapeutics Market Concentration Ratio
3.4.1 Global Endocannabinoid System Targeted Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocannabinoid System Targeted Therapeutics Revenue in 2020
3.5 Endocannabinoid System Targeted Therapeutics Key Players Head office and Area Served
3.6 Key Players Endocannabinoid System Targeted Therapeutics Product Solution and Service
3.7 Date of Enter into Endocannabinoid System Targeted Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Endocannabinoid System Targeted Therapeutics Breakdown Data by Type
4.1 Global Endocannabinoid System Targeted Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Type (2022-2027)

5 Endocannabinoid System Targeted Therapeutics Breakdown Data by Application
5.1 Global Endocannabinoid System Targeted Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Endocannabinoid System Targeted Therapeutics Market Size (2016-2027)
6.2 North America Endocannabinoid System Targeted Therapeutics Market Size by Type
6.2.1 North America Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2027)
6.3 North America Endocannabinoid System Targeted Therapeutics Market Size by Application
6.3.1 North America Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2027)
6.4 North America Endocannabinoid System Targeted Therapeutics Market Size by Country
6.4.1 North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Endocannabinoid System Targeted Therapeutics Market Size (2016-2027)
7.2 Europe Endocannabinoid System Targeted Therapeutics Market Size by Type
7.2.1 Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2027)
7.3 Europe Endocannabinoid System Targeted Therapeutics Market Size by Application
7.3.1 Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2027)
7.4 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country
7.4.1 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Type
8.2.1 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Application
8.3.1 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region
8.4.1 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Endocannabinoid System Targeted Therapeutics Market Size (2016-2027)
9.2 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Type
9.2.1 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Application
9.3.1 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country
9.4.1 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type
10.2.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application
10.3.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country
10.4.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GW Pharmaceuticals
11.1.1 GW Pharmaceuticals Company Details
11.1.2 GW Pharmaceuticals Business Overview
11.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
11.1.4 GW Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
11.1.5 GW Pharmaceuticals Recent Development
11.2 MAKScientific
11.2.1 MAKScientific Company Details
11.2.2 MAKScientific Business Overview
11.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Introduction
11.2.4 MAKScientific Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
11.2.5 MAKScientific Recent Development
11.3 Corbus Pharmaceuticals
11.3.1 Corbus Pharmaceuticals Company Details
11.3.2 Corbus Pharmaceuticals Business Overview
11.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
11.3.4 Corbus Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
11.3.5 Corbus Pharmaceuticals Recent Development
11.4 Tilray
11.4.1 Tilray Company Details
11.4.2 Tilray Business Overview
11.4.3 Tilray Endocannabinoid System Targeted Therapeutics Introduction
11.4.4 Tilray Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
11.4.5 Tilray Recent Development
11.5 Pure Green
11.5.1 Pure Green Company Details
11.5.2 Pure Green Business Overview
11.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Introduction
11.5.4 Pure Green Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
11.5.5 Pure Green Recent Development
11.6 Avicanna
11.6.1 Avicanna Company Details
11.6.2 Avicanna Business Overview
11.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Introduction
11.6.4 Avicanna Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
11.6.5 Avicanna Recent Development
11.7 GB Sciences
11.7.1 GB Sciences Company Details
11.7.2 GB Sciences Business Overview
11.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Introduction
11.7.4 GB Sciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
11.7.5 GB Sciences Recent Development
11.8 Botanix Pharmaceuticals
11.8.1 Botanix Pharmaceuticals Company Details
11.8.2 Botanix Pharmaceuticals Business Overview
11.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
11.8.4 Botanix Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
11.8.5 Botanix Pharmaceuticals Recent Development
11.9 Therapix Biosciences
11.9.1 Therapix Biosciences Company Details
11.9.2 Therapix Biosciences Business Overview
11.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Introduction
11.9.4 Therapix Biosciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
11.9.5 Therapix Biosciences Recent Development
11.10 Zelira Therapeutics
11.10.1 Zelira Therapeutics Company Details
11.10.2 Zelira Therapeutics Business Overview
11.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Introduction
11.10.4 Zelira Therapeutics Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
11.10.5 Zelira Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Inhalation
Table 4. Key Players of Others
Table 5. Global Endocannabinoid System Targeted Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Endocannabinoid System Targeted Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Endocannabinoid System Targeted Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Endocannabinoid System Targeted Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Endocannabinoid System Targeted Therapeutics Market Share by Regions (2022-2027)
Table 11. Endocannabinoid System Targeted Therapeutics Market Trends
Table 12. Endocannabinoid System Targeted Therapeutics Market Drivers
Table 13. Endocannabinoid System Targeted Therapeutics Market Challenges
Table 14. Endocannabinoid System Targeted Therapeutics Market Restraints
Table 15. Global Endocannabinoid System Targeted Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Endocannabinoid System Targeted Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Endocannabinoid System Targeted Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2020)
Table 18. Ranking of Global Top Endocannabinoid System Targeted Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Endocannabinoid System Targeted Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Endocannabinoid System Targeted Therapeutics Product Solution and Service
Table 22. Date of Enter into Endocannabinoid System Targeted Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Endocannabinoid System Targeted Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. GW Pharmaceuticals Company Details
Table 63. GW Pharmaceuticals Business Overview
Table 64. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product
Table 65. GW Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
Table 66. GW Pharmaceuticals Recent Development
Table 67. MAKScientific Company Details
Table 68. MAKScientific Business Overview
Table 69. MAKScientific Endocannabinoid System Targeted Therapeutics Product
Table 70. MAKScientific Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
Table 71. MAKScientific Recent Development
Table 72. Corbus Pharmaceuticals Company Details
Table 73. Corbus Pharmaceuticals Business Overview
Table 74. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product
Table 75. Corbus Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Corbus Pharmaceuticals Recent Development
Table 77. Tilray Company Details
Table 78. Tilray Business Overview
Table 79. Tilray Endocannabinoid System Targeted Therapeutics Product
Table 80. Tilray Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Tilray Recent Development
Table 82. Pure Green Company Details
Table 83. Pure Green Business Overview
Table 84. Pure Green Endocannabinoid System Targeted Therapeutics Product
Table 85. Pure Green Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Pure Green Recent Development
Table 87. Avicanna Company Details
Table 88. Avicanna Business Overview
Table 89. Avicanna Endocannabinoid System Targeted Therapeutics Product
Table 90. Avicanna Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Avicanna Recent Development
Table 92. GB Sciences Company Details
Table 93. GB Sciences Business Overview
Table 94. GB Sciences Endocannabinoid System Targeted Therapeutics Product
Table 95. GB Sciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
Table 96. GB Sciences Recent Development
Table 97. Botanix Pharmaceuticals Company Details
Table 98. Botanix Pharmaceuticals Business Overview
Table 99. Botanix Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Botanix Pharmaceuticals Recent Development
Table 101. Therapix Biosciences Company Details
Table 102. Therapix Biosciences Business Overview
Table 103. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product
Table 104. Therapix Biosciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Therapix Biosciences Recent Development
Table 106. Zelira Therapeutics Company Details
Table 107. Zelira Therapeutics Business Overview
Table 108. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product
Table 109. Zelira Therapeutics Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Zelira Therapeutics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endocannabinoid System Targeted Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Inhalation Features
Figure 4. Others Features
Figure 5. Global Endocannabinoid System Targeted Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Autoimmune Disorders Case Studies
Figure 7. Genetic Disorders Case Studies
Figure 8. Neurological Disorders Case Studies
Figure 9. Pain Disorders Case Studies
Figure 10. Endocannabinoid System Targeted Therapeutics Report Years Considered
Figure 11. Global Endocannabinoid System Targeted Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Endocannabinoid System Targeted Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Endocannabinoid System Targeted Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Endocannabinoid System Targeted Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Endocannabinoid System Targeted Therapeutics Market Share by Players in 2020
Figure 16. Global Top Endocannabinoid System Targeted Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Endocannabinoid System Targeted Therapeutics Revenue in 2020
Figure 18. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Endocannabinoid System Targeted Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Endocannabinoid System Targeted Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Endocannabinoid System Targeted Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Endocannabinoid System Targeted Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Endocannabinoid System Targeted Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Endocannabinoid System Targeted Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Share by Region (2016-2027)
Figure 40. China Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Endocannabinoid System Targeted Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Endocannabinoid System Targeted Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Endocannabinoid System Targeted Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GW Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
Figure 60. MAKScientific Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
Figure 61. Corbus Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
Figure 62. Tilray Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
Figure 63. Pure Green Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
Figure 64. Avicanna Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
Figure 65. GB Sciences Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
Figure 66. Botanix Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
Figure 67. Therapix Biosciences Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
Figure 68. Zelira Therapeutics Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---